Tag Archives: ALNA

Allena Pharmaceuticals (ALNA) Gets a Hold Rating from Credit Suisse

Credit Suisse analyst Martin Auster maintained a Hold rating on Allena Pharmaceuticals (ALNA – Research Report) on February 12 and set a price target of $4.00. The company’s shares closed last Monday at $2.11, close to its 52-week low of

Wedbush Sticks to Their Buy Rating for Allena Pharmaceuticals (ALNA)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Allena Pharmaceuticals (ALNA – Research Report), with a price target of $26.00. The company’s shares closed last Monday at $2.18, close to its 52-week low of

Allena Pharmaceuticals (ALNA) Receives a Buy from Wedbush

Wedbush analyst Liana Moussatos reiterated a Buy rating on Allena Pharmaceuticals (ALNA – Research Report) yesterday and set a price target of $26.00. The company’s shares closed last Monday at $1.95, close to its 52-week low of $1.55. According to

B.Riley FBR Maintains Their Buy Rating on Allena Pharmaceuticals (ALNA)

B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Allena Pharmaceuticals (ALNA – Research Report) today and set a price target of $11.00. The company’s shares closed last Monday at $2.31, close to its 52-week low of $1.55. According

Allena Pharmaceuticals (ALNA) Receives a Buy from Cowen & Co.

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Allena Pharmaceuticals (ALNA – Research Report). The company’s shares closed last Monday at $1.64, close to its 52-week low of $1.55. According to TipRanks.com,

B.Riley FBR Reiterates a Buy Rating on Allena Pharmaceuticals (ALNA)

In a report released today, Mayank Mamtani from B.Riley FBR reiterated a Buy rating on Allena Pharmaceuticals (ALNA – Research Report), with a price target of $11.00. The company’s shares closed last Monday at $2.24, close to its 52-week low